Clinical Trial Update: ctDNA-guided Treatment Decision-making [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ctDNA-guided treatment decision-making in metastatic HER2-negative breast cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Fudan University | Conditions: Metastatic Breast Cancer ( HER2 Negative), ctDNA | Phase 2 | Status: RECRUITING